Literature DB >> 19355886

Potential applications of hydrogen sulfide-induced suspended animation.

Hamid Aslami1, Marcus J Schultz, Nicole P Juffermans.   

Abstract

A suspended animation-like state has been induced in rodents with the use of hydrogen sulfide, resulting in hypothermia with a concomitant reduction in metabolic rate. Also oxygen demand was reduced, thereby protecting against hypoxia. Several therapeutic applications of induction of a hibernation-like state have been suggested, including ischemia-reperfusion injury. More recently, hydrogen sulfide has been found to be protective in states of exaggerated inflammatory responses, such as acute lung injury. Possible mechanisms of this protective effect may include reduction of metabolism, as well as reduction of inflammation. In this manuscript, the methods of inducing a suspended animation-like state in experimental models using hydrogen sulfide are described. We discuss the effects of hydrogen sulfide-induced hypo-metabolism on hemodynamic, metabolic and inflammatory changes in animal models of various hypoxic and inflammatory diseases. In addition, potential therapeutic possibilities of hydrogen sulfide-induced hibernation are outlined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19355886     DOI: 10.2174/092986709787846631

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  Inhaled hydrogen sulfide improves graft function in an experimental model of lung transplantation.

Authors:  Timothy J George; George J Arnaoutakis; Claude A Beaty; Simran K Jandu; Lakshmi Santhanam; Dan E Berkowitz; Ashish S Shah
Journal:  J Surg Res       Date:  2012-06-27       Impact factor: 2.192

2.  Hydrogen sulfide decreases reactive oxygen in a model of lung transplantation.

Authors:  Timothy J George; George J Arnaoutakis; Claude A Beaty; Simran K Jandu; Lakshmi Santhanam; Dan E Berkowitz; Ashish S Shah
Journal:  J Surg Res       Date:  2012-03-18       Impact factor: 2.192

Review 3.  The emerging role of gasotransmitters in the pathogenesis of tuberculosis.

Authors:  Krishna C Chinta; Vikram Saini; Joel N Glasgow; James H Mazorodze; Md Aejazur Rahman; Darshan Reddy; Jack R Lancaster; Adrie J C Steyn
Journal:  Nitric Oxide       Date:  2016-07-04       Impact factor: 4.427

4.  Where will the next generation of stroke treatments come from?

Authors:  D W Howells; G A Donnan
Journal:  PLoS Med       Date:  2010-03-02       Impact factor: 11.069

Review 5.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

6.  The relationship of sleep with temperature and metabolic rate in a hibernating primate.

Authors:  Andrew D Krystal; Bobby Schopler; Susanne Kobbe; Cathy Williams; Hajanirina Rakatondrainibe; Anne D Yoder; Peter Klopfer
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

7.  AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons.

Authors:  Feng-Li Zhao; Fang Fang; Pei-feng Qiao; Ning Yan; Dan Gao; Yong Yan
Journal:  Oxid Med Cell Longev       Date:  2016-01-31       Impact factor: 6.543

8.  Pharmacologically induced reversible hypometabolic state mitigates radiation induced lethality in mice.

Authors:  Subhajit Ghosh; Namita Indracanti; Jayadev Joshi; Jharna Ray; Prem Kumar Indraganti
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

Review 9.  Hypothermia in bleeding trauma: a friend or a foe?

Authors:  Tareq Kheirbek; Ashley R Kochanek; Hasan B Alam
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-12-23       Impact factor: 2.953

10.  Intravenous hydrogen sulfide does not induce neuroprotection after aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury in a human-like porcine model of ubiquitous arteriosclerosis.

Authors:  Andre Bredthauer; Karla Lehle; Angelika Scheuerle; Hubert Schelzig; Oscar McCook; Peter Radermacher; Csaba Szabo; Martin Wepler; Florian Simon
Journal:  Intensive Care Med Exp       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.